Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.

Amy J HobbsNigel T BrocktonT Wayne MatthewsShamir P ChandaranaPinaki BoseKelly GuggisbergGordon H FickJoseph C Dort

Published in: Head & neck (2017)

Patients with p16-positive oropharyngeal SCC had similar outcomes regardless of treatment. Patients with p16-negative tumors may benefit from primary surgery with postoperative adjuvant therapy.

Keyphrases

squamous cell carcinoma
patients undergoing
type diabetes
coronary artery disease
combination therapy
radiation therapy
lymph node metastasis
glycemic control